Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Aphios Awarded SBIR Grant from National Institute on Drug Abuse (NIDA) for Nanotech Formulation of Δ9-THC for Marijuana Addiction and Other Unme

Abstract:
Aphios Corporation today announced receipt of a Phase I Small Business Innovative Research (SBIR) grant from the National Institute on Drug Abuse (NIDA) to develop an improved oral formulation of Δ9-THC for marijuana addiction and unmet medical needs.

Aphios Awarded SBIR Grant from National Institute on Drug Abuse (NIDA) for Nanotech Formulation of Δ9-THC for Marijuana Addiction and Other Unme

WOBURN, MA | Posted on October 28th, 2008

According to Dr. Trevor P. Castor, the grant's Principal Investigator, "In addition to helping marijuana addicts overcome their addiction, the nanotech formulation of Δ9-THC will have applicability in several other chronic diseases such as cancer pain, AIDS wasting, emesis, cachexia, obesity, smoking cessation, schizophrenia, multiple sclerosis and Parkinson's disease."

Innovative and novel dosage formulations are needed to improve the effectiveness and/or minimize the abuse potential of therapeutic agents for drug abuse/dependence. Examples of such agents are buprenorphine and delta-9-tetrahydrocannabinol (Δ9-THC). Buprenorphine has been approved for the treatment of opioid dependence. Sustained-release formulations that reduce the dosing frequency to once a week or once a month are expected to improve compliance thus effectiveness of treatment. Δ9-THC has been shown to alleviate marijuana withdrawal symptoms and has potential for treating marijuana dependence.

In the currently marketed formulation, synthetic Δ9-THC (Dronabinol®) is dissolved in sesame seed oil and is commercially available as an oral capsule (Marinol®). Oral administration causes slow, variable Δ9-THC uptake. In addition, it also requires drug administration several times a day. Δ9-THC is very hydrophobic and oxygen-sensitive, both factors that are challenges in making formulations that are orally bioavailable and stable. Formulations to improve bioavailability and reduce dosing frequency are expected to improve therapeutic effectiveness of Δ9-THC for marijuana addiction.

Aphios plans to utilize its patented SFS-CXP manufacturing technology platform to manufacture pharmaceutical grade Δ9-THC with a >99% purity following cGMP. Aphios will then utilize patented polymer nanospheres nanotechnology platform (SFS-PNS) to encapsulate Δ9-THC in biodegradable polymer nanospheres. Nanoencapsulation will protect Δ9-THC transport to the stomach and enhance its passage across the stomach lining of the gut. Nanoencapsulation will also slow the release of Δ9-THC, controlling the amount of drug in the bloodstream and reducing the frequency of drug administration during the day. Nanoencapsulation in biodegradable polymer nanospheres will thus improve Δ9-THC's stability, prolong circulation time and enhance bioavailability. Alternatively, the formulation will be utilized to deliver Δ9-THC from a subcutaneously implanted depot.

The project described herein was supported by Grant Number 1R43DA024552-01 from the National Institute on Drug Abuse. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.

####

For more information, please click here

Contacts:
Aphios Corporation
Trevor P. Castor, Ph.D.
781-932-6933
CEO

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017

Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

Govt.-Legislation/Regulation/Funding/Policy

Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Graphene holds up under high pressure: Used in filtration membranes, ultrathin material could help make desalination more productive April 24th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Announcements

Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017

Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017

Video captures bubble-blowing battery in action: Researchers propose how bubbles form, could lead to smaller lithium-air batteries April 26th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

SUNY Polytechnic Institute Announces Total of 172 Teams Selected to Compete in Solar in Your Community Challenge: Teams from 40 states, plus Washington, DC, 2 Territories, and 4 American Indian Reservations, Will Deploy Solar in Underserved Communities April 20th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project